311 related articles for article (PubMed ID: 20175930)
1. Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine.
Song J; Socheat D; Tan B; Dara P; Deng C; Sokunthea S; Seila S; Ou F; Jian H; Li G
Malar J; 2010 Feb; 9():57. PubMed ID: 20175930
[TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
[TBL] [Abstract][Full Text] [Related]
3. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
[TBL] [Abstract][Full Text] [Related]
4. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
van der Pluijm RW; Imwong M; Chau NH; Hoa NT; Thuy-Nhien NT; Thanh NV; Jittamala P; Hanboonkunupakarn B; Chutasmit K; Saelow C; Runjarern R; Kaewmok W; Tripura R; Peto TJ; Yok S; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Lek D; Huy R; Dhorda M; Chotivanich K; Ashley EA; Mukaka M; Waithira N; Cheah PY; Maude RJ; Amato R; Pearson RD; Gonçalves S; Jacob CG; Hamilton WL; Fairhurst RM; Tarning J; Winterberg M; Kwiatkowski DP; Pukrittayakamee S; Hien TT; Day NP; Miotto O; White NJ; Dondorp AM
Lancet Infect Dis; 2019 Sep; 19(9):952-961. PubMed ID: 31345710
[TBL] [Abstract][Full Text] [Related]
5. Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial.
McLean ARD; Indrasuta C; Khant ZS; Phyo AK; Maung SM; Heaton J; Aung H; Aung Y; Soe K; Swe MMM; von Seidlein L; Tun NN; Tun KM; Day NPJ; Ashley EA; Hlaing T; Kyaw TT; Dondorp AM; Imwong M; White NJ; Smithuis FM
Lancet Infect Dis; 2021 Nov; 21(11):1579-1589. PubMed ID: 34147154
[TBL] [Abstract][Full Text] [Related]
6. Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa.
Deng C; Huang B; Wang Q; Wu W; Zheng S; Zhang H; Li D; Feng D; Li G; Xue L; Yang T; Tuo F; Mohadji F; Su XZ; Xu Q; Wu Z; Lin L; Zhou J; Yan H; Bacar A; Said Abdallah K; Kéké RA; Msa Mliva A; Mohamed M; Wang X; Huang S; Oithik F; Li XB; Lu F; Fay MP; Liu XH; Wellems TE; Song J
Clin Infect Dis; 2018 Nov; 67(11):1670-1676. PubMed ID: 29846536
[TBL] [Abstract][Full Text] [Related]
7. The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial.
Sutanto I; Suprijanto S; Kosasih A; Dahlan MS; Syafruddin D; Kusriastuti R; Hawley WA; Lobo NF; Ter Kuile FO
Clin Infect Dis; 2013 Mar; 56(5):685-93. PubMed ID: 23175563
[TBL] [Abstract][Full Text] [Related]
8. Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia.
Manning J; Lon C; Spring M; Wojnarski M; Somethy S; Chann S; Gosi P; Soveasna K; Sriwichai S; Kuntawunginn W; Fukuda MM; Smith PL; Rekol H; Sinoun M; So M; Lin J; Satharath P; Saunders D
Trials; 2018 Oct; 19(1):558. PubMed ID: 30326952
[TBL] [Abstract][Full Text] [Related]
9. Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent
Stone W; Mahamar A; Sanogo K; Sinaba Y; Niambele SM; Sacko A; Keita S; Youssouf A; Diallo M; Soumare HM; Kaur H; Lanke K; Ter Heine R; Bradley J; Issiaka D; Diawara H; Traore SF; Bousema T; Drakeley C; Dicko A
Lancet Microbe; 2022 Jan; 3(1):e41-e51. PubMed ID: 35028628
[TBL] [Abstract][Full Text] [Related]
10. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme.
Landier J; Parker DM; Thu AM; Lwin KM; Delmas G; Nosten FH;
Lancet; 2018 May; 391(10133):1916-1926. PubMed ID: 29703425
[TBL] [Abstract][Full Text] [Related]
11. Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment.
Leang R; Taylor WR; Bouth DM; Song L; Tarning J; Char MC; Kim S; Witkowski B; Duru V; Domergue A; Khim N; Ringwald P; Menard D
Antimicrob Agents Chemother; 2015 Aug; 59(8):4719-26. PubMed ID: 26014949
[TBL] [Abstract][Full Text] [Related]
12. Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.
Falq G; Van Den Bergh R; De Smet M; Etienne W; Nguon C; Rekol H; Imwong M; Dondorp A; Kindermans JM
Malar J; 2016 Sep; 15(1):446. PubMed ID: 27585957
[TBL] [Abstract][Full Text] [Related]
13. Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance.
Maude RJ; Socheat D; Nguon C; Saroth P; Dara P; Li G; Song J; Yeung S; Dondorp AM; Day NP; White NJ; White LJ
PLoS One; 2012; 7(5):e37166. PubMed ID: 22662135
[TBL] [Abstract][Full Text] [Related]
14. Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial.
Dicko A; Brown JM; Diawara H; Baber I; Mahamar A; Soumare HM; Sanogo K; Koita F; Keita S; Traore SF; Chen I; Poirot E; Hwang J; McCulloch C; Lanke K; Pett H; Niemi M; Nosten F; Bousema T; Gosling R
Lancet Infect Dis; 2016 Jun; 16(6):674-684. PubMed ID: 26906747
[TBL] [Abstract][Full Text] [Related]
15. Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area.
Song J; Socheat D; Tan B; Seila S; Xu Y; Ou F; Sokunthea S; Sophorn L; Zhou C; Deng C; Wang Q; Li G
Malar J; 2011 Aug; 10():231. PubMed ID: 21827706
[TBL] [Abstract][Full Text] [Related]
16. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.
Thanh NV; Thuy-Nhien N; Tuyen NT; Tong NT; Nha-Ca NT; Dong LT; Quang HH; Farrar J; Thwaites G; White NJ; Wolbers M; Hien TT
Malar J; 2017 Jan; 16(1):27. PubMed ID: 28086775
[TBL] [Abstract][Full Text] [Related]
17. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
Tran TH; Dolecek C; Pham PM; Nguyen TD; Nguyen TT; Le HT; Dong TH; Tran TT; Stepniewska K; White NJ; Farrar J
Lancet; 2004 Jan; 363(9402):18-22. PubMed ID: 14723988
[TBL] [Abstract][Full Text] [Related]
18. The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial.
Okebe J; Bousema T; Affara M; Di Tanna GL; Dabira E; Gaye A; Sanya-Isijola F; Badji H; Correa S; Nwakanma D; Van Geertruyden JP; Drakeley C; D'Alessandro U
EBioMedicine; 2016 Nov; 13():348-355. PubMed ID: 27825738
[TBL] [Abstract][Full Text] [Related]
19. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.
Amato R; Lim P; Miotto O; Amaratunga C; Dek D; Pearson RD; Almagro-Garcia J; Neal AT; Sreng S; Suon S; Drury E; Jyothi D; Stalker J; Kwiatkowski DP; Fairhurst RM
Lancet Infect Dis; 2017 Feb; 17(2):164-173. PubMed ID: 27818095
[TBL] [Abstract][Full Text] [Related]
20. Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials.
Phommasone K; van Leth F; Peto TJ; Landier J; Nguyen TN; Tripura R; Pongvongsa T; Lwin KM; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Nguon C; Davoeung C; Rekol H; Adhikari B; Promnarate C; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Cheah PY; Dhorda M; Imwong M; Mukaka M; Peerawaranun P; Pukrittayakamee S; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Cobelens F; Dondorp AM; White NJ; von Seidlein L
PLoS One; 2020; 15(2):e0228190. PubMed ID: 32023293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]